These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 11986409

  • 1. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
    Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D, Wolfel EE, Lindenfeld J, Tsvetkova T, Robertson AD, Quaife RA, Bristow MR.
    N Engl J Med; 2002 May 02; 346(18):1357-65. PubMed ID: 11986409
    [Abstract] [Full Text] [Related]

  • 2. Coordinate changes in Myosin heavy chain isoform gene expression are selectively associated with alterations in dilated cardiomyopathy phenotype.
    Abraham WT, Gilbert EM, Lowes BD, Minobe WA, Larrabee P, Roden RL, Dutcher D, Sederberg J, Lindenfeld JA, Wolfel EE, Shakar SF, Ferguson D, Volkman K, Linseman JV, Quaife RA, Robertson AD, Bristow MR.
    Mol Med; 2002 Nov 02; 8(11):750-60. PubMed ID: 12520092
    [Abstract] [Full Text] [Related]

  • 3. Changes in myocardial gene expression associated with beta-blocker therapy in patients with chronic heart failure.
    Yasumura Y, Takemura K, Sakamoto A, Kitakaze M, Miyatake K.
    J Card Fail; 2003 Dec 02; 9(6):469-74. PubMed ID: 14966788
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Therapeutic Molecular Phenotype of β-Blocker-Associated Reverse-Remodeling in Nonischemic Dilated Cardiomyopathy.
    Kao DP, Lowes BD, Gilbert EM, Minobe W, Epperson LE, Meyer LK, Ferguson DA, Volkman AK, Zolty R, Borg CD, Quaife RA, Bristow MR.
    Circ Cardiovasc Genet; 2015 Apr 02; 8(2):270-83. PubMed ID: 25637602
    [Abstract] [Full Text] [Related]

  • 8. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
    Chen L, Meyers D, Javorsky G, Burstow D, Lolekha P, Lucas M, Semmler AB, Savarimuthu SM, Fong KM, Yang IA, Atherton J, Galbraith AJ, Parsonage WA, Molenaar P.
    Pharmacogenet Genomics; 2007 Nov 02; 17(11):941-9. PubMed ID: 18075464
    [Abstract] [Full Text] [Related]

  • 9. Effect of cardiac resynchronization therapy on myocardial gene expression in patients with nonischemic dilated cardiomyopathy.
    Iyengar S, Haas G, Lamba S, Orsinelli DA, Babu GJ, Ferketich AK, Yamokoski L, Periasamy M, Abraham WT.
    J Card Fail; 2007 May 02; 13(4):304-11. PubMed ID: 17517351
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of beta-blockers on left ventricular dyssynchrony and reverse remodeling in idiopathic dilated cardiomyopathy: A randomized trial of carvedilol and metoprolol.
    Kaya MG, Sarli B, Akpek M, Kaya EG, Yarlioglues M, Topsakal R, Lam YY.
    Cardiol J; 2014 May 02; 21(4):434-41. PubMed ID: 24142686
    [Abstract] [Full Text] [Related]

  • 11. [Beta blocking agents in the treatment of dilated cardiomyopathy: review of the literature and clinical experience with 67 patients].
    Sinagra G, Perkan A, Di Lenarda A, Lardieri G, Pinamonti B, Mestroni L, Miani D, Camerini F.
    G Ital Cardiol; 1992 Aug 02; 22(8):969-89. PubMed ID: 1362167
    [Abstract] [Full Text] [Related]

  • 12. Beta-blockade in adriamycin-induced cardiomyopathy.
    Noori A, Lindenfeld J, Wolfel E, Ferguson D, Bristow MR, Lowes BD.
    J Card Fail; 2000 Jun 02; 6(2):115-9. PubMed ID: 10908085
    [Abstract] [Full Text] [Related]

  • 13. Marked improvement in left ventricular ejection fraction during long-term beta-blockade in patients with chronic heart failure: clinical correlates and prognostic significance.
    Metra M, Nodari S, Parrinello G, Giubbini R, Manca C, Dei Cas L.
    Am Heart J; 2003 Feb 02; 145(2):292-9. PubMed ID: 12595847
    [Abstract] [Full Text] [Related]

  • 14. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium.
    Lowes BD, Minobe W, Abraham WT, Rizeq MN, Bohlmeyer TJ, Quaife RA, Roden RL, Dutcher DL, Robertson AD, Voelkel NF, Badesch DB, Groves BM, Gilbert EM, Bristow MR.
    J Clin Invest; 1997 Nov 01; 100(9):2315-24. PubMed ID: 9410910
    [Abstract] [Full Text] [Related]

  • 15. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
    Hoshikawa E, Matsumura Y, Kubo T, Okawa M, Yamasaki N, Kitaoka H, Furuno T, Takata J, Doi YL.
    Am J Cardiol; 2011 Apr 01; 107(7):1065-70. PubMed ID: 21296328
    [Abstract] [Full Text] [Related]

  • 16. Effect of beta-blocker therapy on myocardial perfusion defects in thallium-201 scintigraphy in patients with dilated cardiomyopathy.
    Hara Y, Inoue K, Ogimoto A, Ohtsuka T, Shigematsu Y, Nakata S, Higaki J.
    Cardiology; 2005 Apr 01; 104(1):16-21. PubMed ID: 15942178
    [Abstract] [Full Text] [Related]

  • 17. Comparison of low and high doses of carvedilol on restoration of cardiac function and calcium-handling proteins in rat failing heart.
    Sun YL, Hu SJ, Wang LH, Hu Y, Zhou JY.
    Clin Exp Pharmacol Physiol; 2005 Jul 01; 32(7):553-60. PubMed ID: 16026515
    [Abstract] [Full Text] [Related]

  • 18. Treatment of dilated cardiomyopathy with carvedilol in children.
    Erdoğan I, Ozer S, Karagöz T, Celiker A, Ozkutlu S, Alehan D.
    Turk J Pediatr; 2009 Jul 01; 51(4):354-60. PubMed ID: 19950843
    [Abstract] [Full Text] [Related]

  • 19. Long-term effects of carvedilol or metoprolol on left ventricular function in ischemic and nonischemic cardiomyopathy.
    Green P, Anshelevich M, Talreja A, Burcham JL, Ravi SM, Shirani J, Le Jemtel TH.
    Am J Cardiol; 2005 May 01; 95(9):1114-6. PubMed ID: 15842987
    [Abstract] [Full Text] [Related]

  • 20. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A, Azevedo ER, Floras JS, Hollingshead S, Lopaschuk GD, Parker JD.
    Eur J Heart Fail; 2005 Jun 01; 7(4):618-23. PubMed ID: 15921803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.